Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study.
Aaron YarlasAndrew LovleyDuncan BrownMark KosinskiMontserrat Vera-LlonchPublished in: Journal of neurology (2021)
ClinicalTrials.gov Identifier: NCT01737398; Date of registration: November 29, 2012.
Keyphrases